Genmab A/S (GMAB): Price and Financial Metrics
Genmab A/S (GMAB)
Today's Latest Price: $28.97 USD
0.71 (-2.39%)
Updated Jun 4 6:55pm
Add GMAB to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GMAB Daily Price Range
GMAB 52-Week Price Range
GMAB Stock Price Chart More Charts
GMAB Price/Volume Stats
| Current price | $28.97 | 52-week high | $31.30 |
| Prev. close | $29.68 | 52-week low | $16.24 |
| Day low | $28.69 | Volume | 1,902,800 |
| Day high | $29.36 | Avg. volume | 645,748 |
| 50-day MA | $25.12 | Dividend yield | N/A |
| 200-day MA | $22.62 | Market Cap | 18.91B |
Genmab A/S (GMAB) Company Bio
Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its portfolio includes two products, daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998 and is headquartered in Copenhagen, Denmark.
Loading social stream, please wait...